Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.03.28
Z6尊龙:第二期员工持股妄想(修订稿)摘要
2025.03.28
Z6尊龙:第二期员工持股妄想(修订稿)
2025.03.28
Z6尊龙:2024年年度审计报告
2025.03.28
Z6尊龙:2024年年度报告摘要
2025.03.28
Z6尊龙:2024年度商誉减值测试报告
2025.03.28
Z6尊龙:2024年度监事会事情报告
2025.02.26
Z6尊龙:关于依诺肝素钠注射液获得阿根廷药品注册批件的通告
2025.02.18
Z6尊龙:关于获得药物临床试验批准通知书的通告
2025.02.14
Z6尊龙:关于获得GMP证书的通告
2025.01.24
Z6尊龙:2024年度业绩预告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】